Actively Recruiting
Non-Invasive Low Intensity Focused Ultrasound Treatment for Adults Who Have Difficulty Quitting Smoking
Led by The University of Texas Health Science Center, Houston · Updated on 2026-06-23
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating a novel low intensity focused ultrasound LIFU therapy to help people quit cigarette smoking, especially those who struggle to quit despite many serious attempts and existing treatments. Smoking is strongly linked to lung cancers, and new methods are needed to improve cessation success. LIFU is a new, safe technique that can modulate brain activity, targeting deeper brain regions associated with severe nicotine addiction, which current methods cannot directly reach. Participants will be randomly assigned to receive either active LIFU treatment or sham LIFU treatment. Each participant will have two LIFU sessions per week for four weeks. The active LIFU sends acoustic pressure to modulate neural activity in the brain, aiming to support smoking cessation. The sham group receives similar sessions without active stimulation to compare effects. During the study, participants cigarette use per day will be recorded at baseline, after the first session, after the eighth session around four weeks, and at a one-week follow-up. Brain connectivity will be assessed by resting state functional MRI at the first and eighth sessions. Additional measures include carbon monoxide levels in breath, urinary cotinine levels, and quit rates. The study includes safety monitoring and lasts about five weeks from baseline to follow-up.
CONDITIONS
Brief Title
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
Research Team
X
Xiaoming Du, PhD
A
Alina Siatka
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here